Brief: Karyopharm Therapeutics Q4 Net Income USD -30.78 Million
Feb 19 (Reuters) - Karyopharm Therapeutics Q4 operating expenses USD 61.823 million. * Q4 operating income USD -31.281 million * outlook FY revenue USD 140-155 million
Feb 19 (Reuters) - Karyopharm Therapeutics Q4 operating expenses USD 61.823 million. * Q4 operating income USD -31.281 million * outlook FY revenue USD 140-155 million